Clinical Experience with Compression Taping to Treat Seroma After Breast Cancer Surgery: A Medical Device Clinical Study

Clinical Experience with Compression Taping to Treat Seroma After Breast Cancer Surgery: A Medical Device Clinical Study

ObjectiveTo evaluate the safety of compressive taping in patients with seroma secondary to breast cancer surgery.MethodsThis study was a nonrandomized clinical study of medical devices applied to women indicated for seroma aspiration puncture after breast cancer surgery in a public reference hospita...

Full description

Saved in:
Bibliographic Details
Published in:Advances in skin & wound care Vol. 35; no. 7; pp. 1 - 6
Main Authors: Fabro, Erica Alves Nogueira, Teodózio, Clarice Gomes Chagas, Costa, Rejane Medeiros, Macedo, Flávia Oliveira, Cardoso, Aline Cecilia Drumond Dutra Luz Machado, Jacob, Raquel Barroso Evaldt, Thuler, Luiz Claudio Santos, Bergmann, Anke
Format: Journal Article
Language:English
Published: Springhouse Lippincott Williams & Wilkins 01-07-2022
Lippincott Williams & Wilkins Ovid Technologies
Subjects:
Breast cancer
Cancer surgery
Compression therapy
Medical dressings
Wound healing
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ObjectiveTo evaluate the safety of compressive taping in patients with seroma secondary to breast cancer surgery.MethodsThis study was a nonrandomized clinical study of medical devices applied to women indicated for seroma aspiration puncture after breast cancer surgery in a public reference hospital in Brazil. The intervention consisted of applying compressive taping over the seroma fluctuation area and maintained for 5 days. Evaluated outcomes comprised dermal changes caused by taping, subjective symptoms reported during the intervention period, and percent change in the punctured volume before and after the intervention.ResultsA total of 35 women (mean age, 56.7 ± 12.2 years) were included. Most presented with an advanced disease stage (≥IIB; 62.9%). Although a 28.6% incidence of dermal changes caused by taping was observed, an average reduction in the aspirated volume of −28.2 mL was identified (95% confidence interval, −48.3 to −8.0; P = .008). Treatment adherence was high (91.4%), and most patients reported satisfaction with the treatment (85.7%).ConclusionsThe use of compressive taping on seroma areas can be considered safe, is well accepted by patients, and might be used as a noninvasive treatment option for seroma developing after breast cancer surgery.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1527-7941
1538-8654
DOI:10.1097/01.ASW.0000831068.34587.3d